NuVasive Launches AttraX Scaffold Bone Graft

06/08/2018 iData Research

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure San Diego, California-based NuVasive, Inc. has announced the U.S. launch of AttraX Scaffold, the c... Read More

Newly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics

25/06/2018 iData Research

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Datum Biotech Ltd. has announced the founding of Datum Orthobiologics Ltd. Datum Orthobiologics wil... Read More

Medtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants

21/05/2018 iData Research

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Medtronic plc announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft i... Read More

Aziyo Biologics Expands Bone Repair Franchise with Launch of OsteGro

02/04/2018 iData Research

Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced the l... Read More

Polymer Bone Graft Substitute Receives FDA Clearance

07/02/2018 iData Research

Register to receive a free Orthopedic Biomaterials Market Report Suite for US 2017-2023 synopsis and brochure Biotechnology startup Molecular Matrix Inc. has received 510(k) FDA clearance for a carb... Read More

Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment

02/01/2018 iData Research

Anika Therapeutics, Inc., a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, recently announced that its HA-base... Read More

Vivorté Announces the Commercial Availability of FORTERA and REGENTO Bone Grafting Solutions for Orthopedic Surgery

11/10/2017 iData Research

These newly introduced products join Trabexus EB, which first received 510(k) clearance in 2015. TRABEXUS EB is a self-setting, gradually resorbable, calcium phosphate matrix enhanced with partially ... Read More

The Taiwanese Bone Graft Substitute Market: A Small, But Profitable Target

04/10/2017 iData Research

Bone graft substitutes are widely used in a variety of indications, including dental, spine, trauma, large joint, foot & ankle, craniomaxillofacial, and oncology.... Read More

Medtronic Announced New Clinical Tests of Infuse Bone-Growth Product

06/09/2017 iData Research

Firm wants data on best dosage of controversial bone-growth product. ... Read More

Medtronic, Genzyme Lead US Orthopedic Biomaterials Market Due to High R&D Costs Limiting Competition

19/07/2017 iData Research

The U.S. orthopedic biomaterials market is expected to increase to exceed $4.5 billion by 2023... Read More